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Direct evidence supporting a pathophysiological role 
for the peripheral airways in asthma has come from 
studies, where central and peripheral pulmonary 
resistance were compared (1). During both the inspi- 
ration and expiration phases, peripheral resistance 
was significantly increased in asthma patients 
compared with normal individuals, and this was 
particularly evident in patients with moderate to 
severe disease. 
Inflammatory Changes in the Small 
Airways 
Evidence of inflammatory changes in the small air- 
ways has been obtained from microscopic analysis of 
post-mortem samples, which show constriction, 
thickening, and cellular infiltration of the airway wall. 
This technique has a number of disadvantages: the 
bias towards samples from severe cases and possible 
effects of systemic steroid therapy, and the difficulty 
of differentiating changes resulting from the disease 
process from those associated with either tissue pres- 
ervation or caused by death. Immunocytochemical 
staining and molecular biological techniques have 
been found unsatisfactory on such material. 
The alternative technique, that of endoscopic 
biopsy also has disadvantages. It may be unrepre- 
sentative of the region or airway as a whole, since 
only a very small piece can be sampled, and speci- 
mens obtained exclude tissue from beyond the 
smooth muscle. 
Some of the limitations of the above techniques 
have been overcome by the use of frozen, surgically- 
resected lung, but material is available only from a 
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limited number of patients. Samples of this type have 
allowed the airway to be examined systematically, 
with sequential samples being taken from airways 
ranging in diameter from 18 mm to ~2 mm. Studies 
of inflammatory markers in such samples have indi- 
cated that in asthma patients, compared with those 
without asthma, there is a similar increase in T-cell 
number and total eosinophil numbers, and that this 
occurs in both large (~2 mm) and small (~2 mm) 
airways (2). Mast cell numbers have been found to 
change only in small airways. An inverse correlation 
between the size of the airway and the accumulation 
of T-cells and eosinophils has been observed. The 
presence of greater numbers of eosinophils around 
small airways compared to large airways and in 
the parenchyma has been confirmed by immuno- 
histochemical staining (2). 
Inflammatory events in the tissues immediately 
either the side of the smooth muscle layer have also 
been evaluated using the same marker identification 
techniques. This indicated a similar accumulation and 
distribution of T-cells in the two sites, but a greater 
number of resting eosinophils were found outside the 
smooth muscle layer, even in patients with mild 
asthma (2). Conversely, an increased concentration of 
activated (EG2+) eosinophils were identified in tissue 
internal to the muscle layer. There is now evidence 
that smooth muscle may actively participate in the 
recruitment of inflammatory cells by production of 
chemokines, such as eotaxin, MCP-4 and RANTES 
(3,4). Although some expression of eotaxin was noted 
in normal individuals, much higher levels were found 
in asthma patients and occurred in both large and 
small airways, providing further evidence that both 
areas of the lung may participate in eosinophil 
recruitment. 
Tissues examined for evidence of the major inflam- 
matory cytokines implicated in asthma, specifically 
interleukin 4 (IL-4) and IL-5, indicated that the 
number of cells expressing mRNA for each cytokine 
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was increased in asthma patients relative to controls 
(5), but with interesting differences. IL-5 mRNA 
expressiod was greater in the small airways compared 
to the large airways, while the situation was reversed 
for IL-4 mRNA. 
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